A study by researchers at RTI International and the U.S. Centers for Disease Control and Prevention showed that two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million by 2023.
The U.S. Food and Drug Administration has approved a 10 g (50mL) vial size for Hizentra, immune globulin subcutaneous (human).
The U.S. Food and Drug Administration has approved two new quadrivalent influenza vaccines (IIV4s).
The U.S. Food and Drug Administration has launched the Secure Supply Chain Pilot Program (SSCPP) to enable qualified firms to expedite the importation of active pharmaceutical ingredients and finished drugs into the United States.
A total of 4,659 adults aged 18 years or older were randomized to receive a single dose of inactivated quadrivalent influenza vaccine (IIV4) from one of three production lots or an inactivated trivalent influenza vaccine (IIV3) containing either a B/Victoria or B/Yamagata strain.
The National Governors Association reports states are pursuing policies intended to reduce healthcare costs, enhance outcomes and improve access to care for children and pregnant women.
A recombinant factor VIII (rFVIII) featuring a covalent linkage between heavy and light chains and expressed as a single chain molecule has demonstrated “convincing hemostatic efficacy and excellent tolerability” in multiple animal studies, according to CSL Behring researchers.
In July, 22013, the U.S. Department of Health and Human Services awarded $32 million in grants to help identify and enroll uninsured children who are eligible for Medicaid and the Children’s Health Insurance Program (CHIP).
Approximately 1,200 health centers and 9,000 service delivery sites nationwide will receive $150 million in new funding from the Obama administration.
The first vaccine to protect children against the enterovirus 71, or EV71, that causes hand, foot and mouth disease has been developed by Chineses scientists at Beijing Vigoo Biological.
24 states andWashington,D.C., have selected a benchmark insurance plan that will determine what health insurance providers must cover in health plans sold in state exchanges and individual and small-group markets.
In March 2013, the U.S. Department ofHealth and Human Services announced a final rule that provides funding for states that expand Medicaid.